| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1365-2265.2005.02299.X |
| P8608 | Fatcat ID | release_xbe726dvgjfxjddk6mnpco5gnm |
| P698 | PubMed publication ID | 16117808 |
| P5875 | ResearchGate publication ID | 7642551 |
| P2093 | author name string | Channer KS | |
| Jones TH | |||
| Kapoor D | |||
| Malkin CJ | |||
| P2860 | cites work | Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. | Q47359827 |
| A critical evaluation of simple methods for the estimation of free testosterone in serum | Q49081910 | ||
| Insulin and risk of cardiovascular disease: a meta-analysis | Q49102279 | ||
| Serum leptin levels in healthy ageing men: are decreased serum testosterone and increased adiposity in elderly men the consequence of leptin deficiency? | Q49170117 | ||
| Association between plasma total testosterone and cardiovascular risk factors in healthy adult men: The Telecom Study. | Q50975268 | ||
| Low levels of sex hormone-binding globulin and testosterone predict the development of non-insulin-dependent diabetes mellitus in men. MRFIT Research Group. Multiple Risk Factor Intervention Trial. | Q51035704 | ||
| Men with coronary artery disease have lower levels of androgens than men with normal coronary angiograms. | Q51556409 | ||
| Effects of long-term administration of testosterone enanthate on glucose metabolism in rhesus monkeys. | Q51560853 | ||
| Relationship between serum sex hormones and the glucose-insulin-lipid defect in men with obesity. | Q51602477 | ||
| Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study | Q51606964 | ||
| Insulin action and dynamics modelled in patients taking the anabolic steroid methandienone (Dianabol). | Q51631891 | ||
| Induction of insulin resistance by androgens and estrogens | Q56699015 | ||
| Association of increased C-peptide serum levels and testosterone in type 2 diabetes | Q58043323 | ||
| Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man | Q28248505 | ||
| A mathematical comparison of techniques to predict biologically available testosterone in a cohort of 1072 men | Q28275775 | ||
| Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation | Q29547453 | ||
| Androgens and abdominal obesity | Q33637767 | ||
| Effects of testosterone on coronary vasomotor regulation in men with coronary heart disease | Q33877462 | ||
| Endogenous sex hormones and cardiovascular disease in men. A prospective population-based study | Q34177963 | ||
| Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels | Q34227587 | ||
| The assessment of insulin resistance in man. | Q34722579 | ||
| Impact of obesity on hypogonadism in the andropause | Q34744426 | ||
| The vasodilatory action of testosterone: a potassium-channel opening or a calcium antagonistic action? | Q35045086 | ||
| Androgens and coronary artery disease | Q35109614 | ||
| Androgens and cardiovascular disease | Q35146318 | ||
| Testosterone for secondary prevention in men with ischaemic heart disease? | Q35185154 | ||
| Testosterone treatment for men with chronic heart failure | Q35582223 | ||
| Testosterone is a potent inhibitor of L-type Ca(2+) channels | Q40560696 | ||
| Dehydroepiandrosterone supplementation improves endothelial function and insulin sensitivity in men. | Q42169747 | ||
| Low-dose transdermal testosterone therapy improves angina threshold in men with chronic stable angina: A randomized, double-blind, placebo-controlled study | Q43508339 | ||
| The effects of induced hypogonadism on arterial stiffness, body composition, and metabolic parameters in males with prostate cancer | Q43732433 | ||
| Endocrine abnormalities in healthy first-degree relatives of type 2 diabetes patients--potential role of steroid hormones and leptin in the development of insulin resistance | Q43918436 | ||
| Dehydroepiandrosterone-sulfate serum levels and common age-related diseases: results from a cross-sectional Italian study of a general elderly population | Q43928125 | ||
| Effect of obesity and body fat distribution on sex hormones and insulin in men. | Q44107806 | ||
| Sex steroid hormones, upper body obesity, and insulin resistance. | Q44168067 | ||
| Metabolic effects of nandrolone decanoate and resistance training in men with HIV. | Q44185404 | ||
| Prevalence of sarcopenia and predictors of skeletal muscle mass in healthy, older men and women | Q44232726 | ||
| Impact of estrogen replacement therapy in a male with congenital aromatase deficiency caused by a novel mutation in the CYP19 gene | Q44238603 | ||
| Differential contribution of testosterone and estradiol in the determination of cholesterol and lipoprotein profile in healthy middle-aged men. | Q44249460 | ||
| Acute haemodynamic effects of testosterone in men with chronic heart failure | Q44416830 | ||
| Relationships in men of sex hormones, insulin, adiposity, and risk factors for myocardial infarction | Q44473947 | ||
| Reversal of the hypogonadotropic hypogonadism of obese men by administration of the aromatase inhibitor testolactone | Q44594417 | ||
| Sex hormones, inflammation and the metabolic syndrome: a population-based study | Q44670623 | ||
| Partial androgen deficiency in aging type 2 diabetic men and its relationship to glycemic control | Q44887127 | ||
| Insulin inhibits adrenal 17,20-lyase activity in man | Q44927209 | ||
| The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. | Q44968760 | ||
| Disparate effects of weight reduction by diet on serum dehydroepiandrosterone-sulfate levels in obese men and women | Q45081752 | ||
| Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes | Q45142808 | ||
| Lower endogenous androgen levels and dyslipidemia in men with non-insulin-dependent diabetes mellitus | Q46697106 | ||
| P433 | issue | 3 | |
| P921 | main subject | insulin resistance | Q1053470 |
| vascular disease | Q1266890 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 239-250 | |
| P577 | publication date | 2005-09-01 | |
| P1433 | published in | Clinical Endocrinology | Q15762781 |
| P1476 | title | Androgens, insulin resistance and vascular disease in men. | |
| P478 | volume | 63 |
| Q34301287 | A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease |
| Q34167760 | A practical guide to male hypogonadism in the primary care setting |
| Q48410929 | A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with |
| Q37151225 | Androgen deficiency as a predictor of metabolic syndrome in aging men: an opportunity for intervention? |
| Q35632491 | Andropause - state of the art 2015 and review of selected aspects. |
| Q36956546 | Are the adverse effects of glitazones linked to induced testosterone deficiency? |
| Q42290092 | Association Between Commonly Prescribed Opioids and Androgen Deficiency in Men: A Retrospective Cohort Analysis |
| Q37189216 | Association of endogenous sex hormones with diabetes and impaired fasting glucose in men: multi-ethnic study of atherosclerosis |
| Q58291069 | Association of serum androgen concentrations with cardiovascular risk factors in elderly male patients with chronic systolic heart failure in China |
| Q46526834 | Beneficial effects of testosterone administration on symptoms of the lower urinary tract in men with late-onset hypogonadism: a pilot study |
| Q36842367 | Body composition, metabolic syndrome and testosterone in ageing men. |
| Q45021349 | Both total testosterone and sex hormone-binding globulin are independent risk factors for metabolic syndrome: results from Fangchenggang Area Male Health and Examination Survey in China |
| Q64062928 | Bowel preparation for colonoscopy may decrease the levels of testosterone in Korean men |
| Q40029107 | Can Serum Testosterone Be Used as a Marker of Overall Health? |
| Q37430776 | Castration differentially alters basal and leucine-stimulated tissue protein synthesis in skeletal muscle and adipose tissue |
| Q37292076 | Clinicopathologic assessment of hypogonadism in men with type 2 diabetes mellitus |
| Q40782810 | Concurrent Diabetes Mellitus may Negatively Influence Clinical Progression and Response to Androgen Deprivation Therapy in Patients with Advanced Prostate Cancer |
| Q84631304 | Coronary artery disease in men: the role of sex hormones |
| Q21245056 | DHEA administration and exercise training improves insulin resistance in obese rats |
| Q43028516 | DHEA, important source of sex steroids in men and even more in women |
| Q42801114 | Dehydroepiandrosterone reduces preadipocyte proliferation via androgen receptor |
| Q35902890 | Deletion of the androgen receptor in adipose tissue in male mice elevates retinol binding protein 4 and reveals independent effects on visceral fat mass and on glucose homeostasis. |
| Q46886078 | Diagnosing and treating testosterone deficiency in different parts of the world. Results from global market research |
| Q33910958 | Diets rich in saturated and polyunsaturated fatty acids induce morphological alterations in the rat ventral prostate |
| Q50706591 | Dipeptidyl peptidase-4 activity might be a link between tumour necrosis factor alpha and insulin resistance in type 1 diabetes. |
| Q33899266 | Duration of androgen deprivation therapy with maximum androgen blockade for localized prostate cancer |
| Q47243697 | Early weight loss predicts the reduction of obesity in men with erectile dysfunction and hypogonadism undergoing long-term testosterone replacement therapy |
| Q28575457 | Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: in vivo and ex vivo studies |
| Q46161380 | Effect of pioglitazone on testosterone in eugonadal men with type 2 diabetes mellitus: a randomized double-blind placebo-controlled study. |
| Q53601801 | Effect of testosterone on insulin sensitivity, oxidative metabolism and body composition in aging men with type 2 diabetes on metformin monotherapy. |
| Q43959465 | Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes |
| Q37212024 | Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome? |
| Q59813297 | Effects of testosterone undecanoate replacement and withdrawal on cardio-metabolic, hormonal and body composition outcomes in severely obese hypogonadal men: a pilot study |
| Q43134642 | Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome |
| Q46889850 | Erectile dysfunction is associated with low bioactive testosterone levels and visceral adiposity in men with type 2 diabetes |
| Q89559741 | Frequency of Hypogonadism in Type 2 Diabetes Mellitus Patients with and without Coronary Artery Disease |
| Q43672165 | Gender differences in the cardiovascular effect of sex hormones |
| Q35654409 | Hemoglobin and Ferritin Concentrations in Subjects with Metabolic Syndrome |
| Q33569163 | Hormone replacement therapy and physical function in healthy older men. Time to talk hormones? |
| Q37671150 | Hypogonadism and metabolic syndrome in nigerian male patients with both type 2 diabetes and hypertension |
| Q35852422 | Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy |
| Q37280879 | Hypogonadotrophic hypogonadism in type 2 diabetes |
| Q36796043 | Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study |
| Q34422927 | Influence of testosterone replacement therapy on metabolic disorders in male patients with type 2 diabetes mellitus and androgen deficiency |
| Q30405254 | Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period |
| Q100467639 | LPCN 1144 Resolves NAFLD in Hypogonadal Males |
| Q37789736 | Late onset hypogonadism, sexuality and fertility. |
| Q36839032 | Lower urinary-tract symptoms and testosterone in elderly men |
| Q91787106 | Male hypogonadism: 14-year prospective outcome in 550 men with type 2 diabetes |
| Q37319725 | Management of erectile dysfunction in diabetes: an update for 2008. |
| Q34884322 | Men's health, low testosterone, and diabetes: individualized treatment and a multidisciplinary approach |
| Q38822114 | Obesity and Hypogonadism |
| Q38680759 | Obesity and sex interact in the regulation of Alzheimer's disease |
| Q35796644 | Obesity and testosterone levels in Ghanaian men with type 2 diabetes |
| Q46919860 | Oestradiol replacement treatment and glucose homeostasis in two men with congenital aromatase deficiency: evidence for a role of oestradiol and sex steroids imbalance on insulin sensitivity in men. |
| Q90009281 | Olive Oil Nutraceuticals in the Prevention and Management of Diabetes: From Molecules to Lifestyle |
| Q46807792 | Prevalence of metabolic syndrome in long-term survivors of hematopoietic stem cell transplantation |
| Q87917030 | Primary androgen deprivation therapy as monotherapy in unfavourable intermediate- and high-risk localised prostate cancer: a Singaporean single-centre perspective |
| Q43176618 | Relationship between insulin and hypogonadism in men with metabolic syndrome |
| Q41976574 | Relationship between insulin resistance, obesity and serum prostate-specific antigen levels in healthy men |
| Q46553591 | Rosiglitazone increases bioactive testosterone and reduces waist circumference in hypogonadal men with type 2 diabetes |
| Q43176630 | Serum testosterone and cardiovascular disease in men |
| Q42338932 | Sex Hormones and Colorectal Cancer: What Have We Learned So Far? |
| Q34014004 | Sex-dependent role of glucocorticoids and androgens in the pathophysiology of human obesity |
| Q37192036 | Sexual dimorphism of the aging kidney: role of nitric oxide deficiency |
| Q43157280 | Sexual health as a portal to men's health: a problem turned around into an opportunity |
| Q43176620 | Short term testosterone replacement therapy improves libido and body composition |
| Q38139822 | Sperm parameters: paradigmatic index of good health and longevity |
| Q37007642 | Study of Sex Hormone-binding Globulin Gene Polymorphism and Risk of Type 2 Diabetes Mellitus in Egyptian Men. |
| Q37104386 | Survival following primary androgen deprivation therapy among men with localized prostate cancer |
| Q35968107 | Testosterone and metabolic syndrome: The link |
| Q38485746 | Testosterone and obesity |
| Q36327973 | Testosterone and the metabolic syndrome |
| Q38363704 | Testosterone deficiency, insulin-resistant obesity and cognitive function |
| Q24647679 | Testosterone for the aging male; current evidence and recommended practice |
| Q37262459 | Testosterone levels in suicide attempters with bipolar disorder |
| Q36987403 | Testosterone replacement therapy |
| Q90575050 | The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts |
| Q51495046 | The effect of testosterone on insulin sensitivity in men with heart failure. |
| Q64104589 | The effects of testosterone replacement therapy on the prostate: a clinical perspective |
| Q42114446 | The incidence of hypogonadotropic hypogonadism in type 2 diabetic men in Polish population |
| Q38057355 | The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism |
| Q36575143 | The triad of erectile dysfunction, hypogonadism and the metabolic syndrome. |
| Q58296612 | Visceral obesity, the metabolic syndrome, androgens and estrogens |
| Q37378541 | Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. |
| Q87939333 | Yang-tonifying traditional Chinese medicinal plants and their potential phytoandrogenic activity |
Search more.